Jpmorgan Chase & CO Organon & Co. Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Organon & Co. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 633,330 shares of OGN stock, worth $9.43 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

633,330

Previous 684,957 7.54%

Holding current value

$9.43 Million

Previous $14.2 Million 14.55%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Dec 26, 2024	SELL	$18.65 - $23.03 $962,843 - $1.19 Million	-51,627 Reduced 7.54%	633,330 $12.1 Million
Q3 2024 Nov 08, 2024	SELL	$18.65 - $23.03 $962,843 - $1.19 Million	-51,627 Reduced 7.54%	633,330 $12.1 Million
Q2 2024 Dec 26, 2024	BUY	$17.45 - $21.96 $900,891 - $1.13 Million	51,627 Added 8.15%	684,957 $14.2 Million
Q2 2024 Aug 12, 2024	BUY	$17.45 - $21.96 $565,729 - $711,943	32,420 Added 4.97%	684,957 $14.2 Million
Q1 2024 Dec 26, 2024	BUY	$13.78 - $18.8 $264,672 - $361,091	19,207 Added 3.03%	652,537 $12.3 Million
Q1 2024 May 10, 2024	SELL	$13.78 - $18.8 $2.92 Million - $3.98 Million	-211,926 Reduced 24.52%	652,537 $12.3 Million
Q4 2023 Dec 26, 2024	BUY	$10.95 - $17.32 $2.53 Million - $4 Million	231,133 Added 36.49%	864,463 $12.5 Million
Q4 2023 Feb 12, 2024	SELL	$10.95 - $17.32 $4.07 Million - $6.44 Million	-371,635 Reduced 30.07%	864,463 $12.5 Million
Q3 2023 Nov 14, 2023	SELL	$16.59 - $23.77 $2.48 Million - $3.56 Million	-149,728 Reduced 10.8%	1,236,098 $21.5 Million
Q2 2023 Aug 11, 2023	BUY	$19.27 - $24.63 $13.4 Million - $17.1 Million	695,255 Added 100.68%	1,385,826 $28.8 Million
Q1 2023 May 18, 2023	BUY	$21.42 - $32.08 $5.38 Million - $8.06 Million	251,380 Added 57.24%	690,571 $16.2 Million
Q1 2023 May 11, 2023	SELL	$21.42 - $32.08 $12.1 Million - $18.1 Million	-562,676 Reduced 56.16%	439,191 $10.3 Million
Q4 2022 Feb 13, 2023	SELL	$23.31 - $28.61 $26.6 Million - $32.6 Million	-1,141,115 Reduced 53.25%	1,001,867 $28 Million
Q3 2022 Nov 14, 2022	SELL	$23.4 - $34.25 $3.01 Million - $4.4 Million	-128,556 Reduced 5.66%	2,142,982 $50.1 Million
Q2 2022 Aug 11, 2022	BUY	$31.66 - $38.9 $13.7 Million - $16.9 Million	434,292 Added 23.64%	2,271,538 $76.7 Million
Q1 2022 May 11, 2022	SELL	$30.45 - $39.36 $45.6 Million - $59 Million	-1,498,812 Reduced 44.93%	1,837,246 $64.2 Million
Q4 2021 Feb 10, 2022	BUY	$28.67 - $37.13 $2.68 Million - $3.47 Million	93,481 Added 2.88%	3,336,058 $102 Million
Q3 2021 Nov 12, 2021	BUY	$28.63 - $35.64 $92.8 Million - $116 Million	3,242,577 New	3,242,577 $106 Million

Others Institutions Holding OGN

# of Institutions

795

Shares Held

204M

Call Options Held

1.71M

Put Options Held

870K

View Full List

About Organon & Co.

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.79B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

More about OGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Organon & Co. Transaction History